31 Mar 2021
Assets8.22
Total Income36.75
Profit After Tax0.73
NET Worth0.94
Reserves and Surplus0.93
Total Borrowing3.02
At a glance
Updated 2026-08-23Saroja Pharma Industries is a SME IPO with an issue size of ₹9.11 crore, proposed for listing on NSE SME. The offer opens on 31st Aug 2023 and closes on 5th Sep 2023. The issue structure includes a fresh issue of ₹8.66 crore.
Issue details
Listing atNSE SME
Issue typeFixed Price Issue
Issue size₹9.11 Cr
Fresh issue₹8.66 Cr
Face value₹10
Price band—–—
Allotment8th Sep 2023
Listing13th Sep 2023
Grey market
GMP page ↗Latest GMP₹0.00
GMP / upper priceNO DATA
Est. listing₹84.00
GMP is unofficial sentiment data, not an exchange price.
Timeline
Opens31st Aug 2023
Closes5th Sep 2023
Allotment8th Sep 2023
Refund11th Sep 2023
Demat12th Sep 2023
Listing13th Sep 2023
Subscription demand
Full bidding ↗Total8.88×
Lot size
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 1600 | — |
Company
Incorporated2019
Use of proceeds
| Object | Amount |
|---|---|
| To Set-up a Manufacturing Unit | ₹7.05 Cr |
| To Repay the Unsecured Loans | ₹1.75 Cr |
Financials
Full financials ↗31 Mar 2022
Assets15.51
Total Income55.96
Profit After Tax1.14
NET Worth4.03
Reserves and Surplus3.80
Total Borrowing6.14
31 Mar 2023
Assets21.34
Total Income50.35
Profit After Tax1.06
NET Worth5.09
Reserves and Surplus2.15
Total Borrowing10.19
Trend chart₹ crore
KPIs
| KPI | Mar 31, 2023 |
|---|---|
| ROE | 15% |
| ROCE | 25% |
| Debt / Equity | 2.00% |
| RoNW | 20.85% |
| PAT Margin | 2.11% |
| EBITDA Margin | 5.73% |
| Price to Book Value | 4.85 |
Valuation & shareholding
Pre-IPO EPS3.61
Post-IPO EPS2.64
Pre-IPO P/E23.25
Post-IPO P/E31.84
Promoter holding pre100%
Promoter holding post73.02%
Market cap₹33.77 Cr.
Issue expenses
| Expense | Amount |
|---|---|
| Lead Manger Fees including Underwriting Commission | ₹0.23 Cr |
| Fees Payable to Registrar to the Issue | ₹0.01 Cr |
| Fees Payable Advertising, Marketing Expenses and Printing Expenses | ₹0.03 Cr |
| Fees Payable to Regulators including Stock Exchanges and other Intermediaries | ₹0.04 Cr |
| Fees payable to Peer Review Auditor and other advisor | ₹0.01 Cr |
Registrar & lead managers
Registrar
Kfin Technologies Ltd.Lead managers
- Swastika Investmart Ltd.
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-08-23.